VCEL FY 2020 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$124M+5.4% YoY

Gross Profit

$84M67.8% margin

Operating Income

$2M1.9% margin

Net Income

$3M2.3% margin

EPS (Diluted)

$0.06

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$15M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$206M

Total Liabilities

$71M

Stockholders' Equity

$134M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$124M	$118M	+5.4%
Gross Profit	$84M	$80M	+4.9%
Operating Income	$2M	-$11M	+121.1%
Net Income	$3M	-$10M	+129.6%